Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
3(30%)
Results Posted
50%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
2
20%
Ph phase_1
4
40%
Ph phase_2
4
40%

Phase Distribution

4

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
4(40.0%)
Phase 2Efficacy & side effects
4(40.0%)
N/ANon-phased studies
2(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(3)
Completed(4)
Terminated(1)
Other(2)

Detailed Status

Completed4
unknown2
Recruiting2
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
80.0%
Most Advanced
Phase 2

Trials by Phase

Phase 14 (40.0%)
Phase 24 (40.0%)
N/A2 (20.0%)

Trials by Status

terminated110%
completed440%
unknown220%
active_not_recruiting110%
recruiting220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10